Chemestmed
PrivateLast Round
Grant
Jun 10, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Chemestmed operates in Healthcare & Life Sciences and is based in Tartu. It was founded in 2011.
Chemestmed is a biotechnology company that develops small-molecule therapeutics for the treatment of cancer, neurodegenerative, and metabolic disorders by regulating RNA methylation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chemestmed Comparables
Compare Chemestmed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| STORM Therapeutics | 86% | |
| Ribometrix | 83% | |
| ReviR Therapeutics | 81% |
For institutional investors. Book with your work email.
Chemestmed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 10, 2026 | ||||
| Grant | Dec 19, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Chemestmed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 231% MoM, reaching 1.7K.
- Jun 10, 2026
Received grant funding from the European Innovation Council.
For institutional investors. Book with your work email.
Chemestmed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Chemestmed's valuation, stock price, and market status.
Is Chemestmed a public or private company?
Chemestmed is a private company.
What is the current stock price of Chemestmed?
Chemestmed is a private company, so its shares have no public market price. Caplight tracks Chemestmed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Chemestmed worth (valuation)?
Valuation information for Chemestmed is not publicly available.
Can I buy Chemestmed stock?
Chemestmed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Chemestmed's last funding round?
Chemestmed's most recent funding round was Grant on June 10, 2026.
Who are the main investors in Chemestmed?
Key investors in Chemestmed include European Innovation Council.
Will Chemestmed IPO soon?
No public IPO plans have been announced for Chemestmed.
How can I track Chemestmed secondary market activity?
Caplight tracks bids, offers, and trades in Chemestmed's shares on secondary markets.